Neurocrine Bio. (NBIX): KOL Expects Significant Uptake of Elagolix in Endometriosis, Tougher Sell in Uterine Fibroids - Jefferies
Go back to Neurocrine Bio. (NBIX): KOL Expects Significant Uptake of Elagolix in Endometriosis, Tougher Sell in Uterine Fibroids - Jefferies| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 134.56 +2.82 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $131.74 | 52 Week High | $58.46 | |||
| Open | $131.78 | 52 Week Low | $31.25 | |||
| Day High | $135.18 | P/E | N/A | |||
| Day Low | $131.49 | EPS | $-0.69 | |||
| Volume | 392,987 | |||||
